Neurological Diseases

Prevalence of neurological diseases such as dementia, Alzheimer’s disease, and Parkinson’s disease is rising, significantly disrupting quality of life for patients and their families. Research indicates that not only are these diseases affecting more people, they are also starting earlier and resulting in more deaths than ever before.

Unfortunately, there is no cure for many neurological diseases. While conventional treatments may address specific symptoms and potentially delay disease progression to some extent, true recovery is often impossible. In the absence of curative conventional treatment, researchers, clinicians, and patients are increasingly seeking out alternative therapies to find more complete symptom relief and potentially delay progression.

Today, a growing body of research is emerging in support of nutritional therapies that may play a meaningful role in the treatment of neurological diseases. Foundational Medicine Review believes that exploring the possibilities of these treatments is critical to ensuring both clinicians and patients understand their options and make informed choices regarding care.

Read our latest articles

dietary supplement for autism

Is There an Ideal Dietary Supplement for Autism? A Look at the Most Promising Options

acetaldehyde and hangovers

Acetaldehyde and Hangovers: Understanding the Role of Phenolic Compounds in Treatment

gut-brain axis and anxiety

Understanding the Connection Between the Gut-Brain Axis and Anxiety: The Role of the Bacteria in the Microbiome

Understanding the Connection Between the Gut-Brain Axis and Anxiety: The Role of the Bacteria in the Microbiome

gut-brain axis and anxiety

patients who struggle with anxiety spend years (or even decades) trying to find a treatment option that truly works to address their symptoms, often without achieving durable relief. Indeed, ...

Considering Supplementation with Polyphenols as an Alternative Treatment for Alzheimer’s Disease

alternative treatment for Alzheimer’s disease

When it comes to the treatment of Alzheimer’s disease, there’s no denying that the currently available treatments are suboptimal. So far, the FDA has only approved two classes of drugs for Alzheimer’s disease—cho...